Egypt is intensifying efforts to strengthen pharmaceutical research and innovation through closer cooperation with Takeda Pharmaceutical Company, as part of a broader strategy to enhance the country’s healthcare and drug development ecosystem. The Egyptian Drug Authority (EDA) held high-level talks with a senior delegation from Takeda to discuss expanding collaboration in scientific research and improving Egyptian patients’ access to innovative treatments. El-Ghamrawy stressed the Authority’s commitment to supporting research initiatives and expanding the clinical trials framework in Egypt, noting that such efforts are key to positioning the country as a regional hub for pharmaceutical research and development. For their part, officials from Takeda Pharmaceutical Company expressed appreciation for the constructive partnership with the Authority and praised its role in strengthening the national pharmaceutical landscape and research environment. They reaffirmed the company’s intention to expand its operations in Egypt, particularly in research, development, and clinical trials, to accelerate pharmaceutical innovation and ensure broader access to advanced treatments.

Source: Daily News Egypt March 17, 2026 18:12 UTC